Obstet Gynecol Sci.  2020 Sep;63(5):553-554. 10.5468/ogs.20085.

Safety and feasibility of robotic surgery in selected ovarian cancer patients undergoing interval debulking surgery

• Iavazzo C
• Gkegkes ID

• KMID: 2506497
• DOI: http://doi.org/10.5468/ogs.20085

Reference

References

1. Carbajal-Mamani SL, Schweer D, Markham MJ, Esnakula AK, Grajo JR, Castagno JC, et al. Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study. Obstet Gynecol Sci. 2020; 63:150–7.

2. Fagotti A, Gueli Alletti S, Corrado G, Cola E, Vizza E, Vieira M, et al. The INTERNATIONAL MISSION study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy. Int J Gynecol Cancer. 2019; 29:5–9.

3. Shi C, Gao Y, Yang Y, Zhang L, Yu J, Zhang T. Comparison of efficacy of robotic surgery, laparoscopy, and laparotomy in the treatment of ovarian cancer: a meta-analysis. World J Surg Oncol. 2019; 17:162.

4. Cardenas-Goicoechea J, Wang Y, McGorray S, Saleem MD, Carbajal Mamani SL, Pomputius AF, et al. Minimally invasive interval cytoreductive surgery in ovarian cancer: systematic review and meta-analysis. J Robot Surg. 2019; 13:23–33.

5. Abitbol J, Gotlieb W, Zeng Z, Ramanakumar A, Kessous R, Kogan L, et al. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy. Int J Gynecol Cancer. 2019; 29:1341–7.